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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYPerturbations in stem cell activity and differentiation can lead to developmental defects and cancer. We use an approach involving a
quantitative model of cell-state transitions in vitro to gain insights into how SLUG/SNAI2, a key developmental transcription factor,
modulates mammary epithelial stem cell activity and differentiation in vivo. In the absence of SLUG, stem cells fail to transition into
basal progenitor cells, while existing basal progenitor cells undergo luminal differentiation; together, these changes result in abnormal
mammary architecture and defects in tissue function. Furthermore, we show that in the absence of SLUG, mammary stem cell activity
necessary for tissue regeneration and cancer initiation is lost. Mechanistically, SLUG regulates differentiation and cellular plasticity by
recruiting the chromatin modifier lysine-specific demethylase 1 (LSD1) to promoters of lineage-specific genes to repress transcription.
Together, these results demonstrate that SLUG plays a dual role in repressing luminal epithelial differentiation while unlocking stem
cell transitions necessary for tumorigenesis.INTRODUCTION
In renewable tissues such as the hematopoietic system,
skin, and intestine, multipotent stem cells serve as a reser-
voir of cells that are called upon to maintain tissue homeo-
stasis and function (Blanpain and Fuchs, 2006; Tesori et al.,
2013; Toma et al., 2001; Barker et al., 2008; Weissman,
2000). These stem cells have been implicated as precursors
to cancer, presumably due to their long-term persistence
and high self-renewing capabilities (Barker et al., 2009;
Bonnet and Dick, 1997). However, in other tissues such
as the mammary gland, lineage-restricted progenitor cells,
as opposed to multipotent stem cells, are responsible for
tissue maintenance and homeostasis (Van Keymeulen
et al., 2011). When called upon for tissue regeneration, as
is the case upon transplantation or injury, these lineage-
committed progenitor cells unlock primitive stem cell
programs that are not normally required for tissue develop-
ment or tissue homeostasis (Blanpain et al., 2004; Doupe´
et al., 2012; Kordon and Smith, 1998; Shackleton et al.,
2006; Stingl et al., 2006; van Amerongen et al., 2012; Van
Keymeulen et al., 2011). By doing so, these cells acquire
properties that make them amenable to cancer initiation
(Pacheco-Pinedo et al., 2011; Proia et al., 2011; SchwitallaSteet al., 2013; Youssef et al., 2010, 2012). However, themolec-
ular mechanism by which committed progenitor cells
access latent stem cell programs is not well understood.
Previously, we showed that the transcription factor SLUG
is an important regulator of mammary epithelial lineage
commitment and differentiation (Proia et al., 2011). Recent
studies have also shown that SLUG is necessary for the
mammary stem cell state (Guo et al., 2012). However,
SLUG-deficient mice develop mammary glands, and trans-
plantation of tissue fragments from these mice were able to
fully regenerate functional mammary glands; this suggests
that SLUGmight be dispensable for stem cell activity (Nas-
sour et al., 2012). Thus, the precise role of SLUG in mam-
mary stem and progenitor cell dynamics remains unclear.
The ability to study stem cell-state transitions and pro-
genitor cell dynamics in vivo is challenging; even when
cell-state markers are available, most transitions are short-
lived and difficult to capture. We sought to gain insights
into how SLUG controls stem cell activity in normal dis-
ease-free mammary epithelial cells by using a recently
developed and validated quantitative model to predict
cell-state transition rates in vitro (Gupta et al., 2011). Using
this approach, we were able to (1) infer differences in cell-
state transition probabilities between wild-type (WT) andm Cell Reports j Vol. 2 j 633–647 j May 6, 2014 j ª2014 The Authors 633
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accurately predict the in vivo phenotype associated with
SLUG deficiency, and (3) provide insights into how SLUG
inhibition influences progenitor cell dynamics to ulti-
mately disrupt cellular differentiation as well as tissue
homeostasis, regeneration, and tumor initiation.RESULTS
SLUG Inhibits Differentiation of Breast Epithelial
Cells
SLUG could be regulating stem cell activity by preventing
proliferation, by inhibiting differentiation, or by affecting
cell-state transitions between stem cells and lineage-
committed cells. To begin to distinguish between these
possibilities, we used lentiviral-mediated short hairpin
RNA to knockdown SLUG in human basal progenitor cell
lines: human telomerase reverse transcriptase (hTERT)
immortalized mammary epithelial cells (HMECs) derived
from two different patient samples and the spontaneously
immortalizedMCF10Abreast epithelial cell line (Figure 1A).
In agreementwith our previous findings (Proia et al., 2011),
SLUG-inhibited (shSlug) HMECs adopted a tightly packed
cobblestone-like appearance compared to control cells
(shControl), consistent with a more differentiated epithe-
lial cell phenotype (Figure S1A available online).
To more comprehensively define the phenotype associ-
ated with SLUG inhibition in mammary progenitor
cells, we performed global gene expression analysis on
shControl and shSlug HMEC and MCF10A cells (Supple-
mental Experimental Procedures). Gene Ontology (GO)Figure 1. SLUG Inhibits Differentiation of Breast Epithelial Cells
(A) Western blot analysis of SLUG expression in shControl and shSlug
(B) Gene Ontology biological process categories upregulated following
MCF10A cells. The DAVID Functional Annotation Tool (Huang da et al.,
the enrichment score and p value of genes differentially expressed in
(C) Hierarchical clustering heatmap of shSlug HMEC (patient 1) and s
line) using the 50-gene set of the PAM50 breast cancer intrinsic sub
(D) Relative enrichment of mature luminal, luminal progenitor, basal/
HMEC (patient 1) and MCF10A cells compared to shControl cells.
(E) Relative mRNA expression levels (normalized to GAPDH) of lumin
following SLUG inhibition. Genes differentially expressed in the shSlu
(F) Quantitative real-time PCR analysis of luminal marker expression
Genes differentially expressed in shSlug cells compared to shContro
independent experiments, and p values were calculated by Student’s
(G) Immunofluorescent staining for the luminal marker EPCAM in MCF1
quantification is depicted in the graph below. Data represent the m
calculated by Student’s two-tailed t test. Scale bars represent 100 mm
(H) Phase-contrast images of MCF10A cells grown in 3D culture. Quanti
by shControl and shSlug MCF10A cells. Data represent the mean ± SD
Student’s two-tailed t test.
See also Figure S1.
Steanalysis revealed significant enrichment of genes involved
in epithelial cell differentiation, ectoderm development,
secretion, and the regulation of cell adhesion in SLUG-
inhibited HMECs and MCF10A cells (Figure 1B). To further
assess breast epithelial differentiation, microarray data
were analyzed using the recently described Genomic
Differentiation Predictor (Prat et al., 2010) and the 50 genes
of the PAM50 breast cancer intrinsic subtype predictor
(Parker et al., 2009). As predicted, SLUG inhibition led to
significant changes in the expression of epithelial-related
genes in both HMECs and MCF10A cells (Figure 1C;
Figure S1B). Notably, there was increased expression of
luminal genes (e.g., FOXA1, BAG1, and NAT1) and
decreased expression of proliferation genes (e.g., MKI67,
CDC6, and CDCA1) in both cell lines (Figure 1C;
Gene Expression Omnibus [GEO] accession number
GSE54735). Furthermore, when probed for signatures of
lineage-specific mammary epithelial subpopulations (Lim
et al., 2009), SLUG inhibition resulted in a significant
enrichment in the luminal progenitor signature in both
cell lines, while HMECs also displayed a significant enrich-
ment in the mature luminal profile (Figure 1D). Transcrip-
tional analysis using quantitative RT-PCR further
confirmed the strong induction of luminal differentiation
genes, with a concomitant decrease in the expression of
genes associated with basal/stem differentiation following
SLUG knockdown (Figures 1E and 1F). Consistent with
these data, immunofluorescence analysis for the luminal
marker EPCAM revealed a significant increase in its expres-
sion upon SLUG knockdown in MCF10A cells (Figure 1G).
Differentiation and morphogenesis of control and
shSlug MCF10A cells was also evaluated using a 3DHMECs and MCF10A cells.
SLUG inhibition in mammary epithelial cells: HMECs (patient 1) and
2009) was used to identify categories with an enrichment score >2;
the microarray are shown.
hSlug MCF10A cells compared to shControl cells (n = 3 for each cell
type predictor. No gene centering was performed.
stem, and stromal signatures (defined by Lim et al., 2009) in shSlug
al and basal markers in two different patient-derived HMEC lines
g cells compared to the control cells (dashed line) are plotted.
(normalized to GAPDH) in MCF10A cells following SLUG inhibition.
l cells are plotted. Bars represent the fold change ± SD of three
two-tailed t test. *p < 0.05, **p < 0.005.
0A shControl and shSlug cells. Representative images are shown and
ean ± SEM of three independent experiments, and p values were
.
fication of the percentage of round, ductal, and flat colonies formed
of three independent experiments, and p values were calculated by
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SLUG Regulates Mammary Cell-State Transitionscollagen/Matrigel assay. In these 3D cultures, luminal
progenitor cells primarily differentiate into round alveolar
colonies while basal progenitor cells form distinct flat
colonies and branching ductal colonies (Keller et al.,
2012). As expected, SLUG inhibition led to a significant
increase in the formation of round alveolar colonies and
a significant decrease in the number of flat and ductal struc-
tures following growth on collagen (Figure 1H). Together,
these data fortify SLUG as a critical repressor of breast
epithelial differentiation.
Modeling the Effect of SLUG on Cell-State Transition
Rates
While the above findings clearly highlight SLUG’s influ-
ence on inhibiting mammary epithelial cell (MEC)
differentiation, they do not divulge the dynamic cellular
mechanisms that may be affecting cell-state transitions
between stem cells and lineage-committed cells. To begin
to address this, we examined breast epithelial cell-state pro-
portions by fluorescence-activated cell sorting following
SLUG inhibition. In cultured cells, luminal cells display
EPCAM+ and CD24+ immunophenotypes, while basal cells
exhibit EPCAM/CD49f+ and CD24/CD49f+ immuno-
phenotypes (Eirew et al., 2008; Keller et al., 2010, 2012;
Lim et al., 2009). Consistent with the gene expression
data, SLUG inhibition resulted in increased proportions of
CD24+ and EPCAM+ luminal cells and concomitant
decreased proportions of CD24/CD49f+ and EPCAM/
CD49f+ basal/progenitor cells (Figure 2A; Figures S2A–S2E).
To provide dynamic insights into how SLUG deficiency
impacts these cell-state shifts, we employed a quantitative
Markov model that has recently been used to study the dy-
namics of cell-state proportions in human breast cancer
cell lines (Gupta et al., 2011). With this model, data gener-Figure 2. Loss of SLUG Alters Stochastic Cell-State Interconversi
(A) Flow cytometry analysis of luminal (EPCAM and CD24) and basal (
MCF10A cells. Representative dot plots for EPCAM versus CD49f expre
calculated by Student’s two-tailed t test.
(B) Flow cytometry gating strategy for isolating luminal (CD24+/EP
EPCAM/CD49f+) subpopulations from a heterogeneous parental MCF
(C) Expression of various differentiation-related genes in luminal, b
platform (Nanostring Technologies) (Geiss et al., 2008). The heatm
expression across the three cell states. Data presented have been gen
(D) Flow cytometry analysis showing the proportion of cells in the lumi
populations immediately prior to sorting. Data represent the mean ±
Student’s two-tailed t test.
(E) Schematic of the experimental procedure used to calculate cell-st
(F) Predicted cell-state transition probabilities for shControl and sh
cell-state transitions in shControl and shSlug cells. Each transition
transitions that changed >1.5-fold following SLUG inhibition are sho
(G) In vitro proliferation curves of purified subpopulations (luminal, st
fluorescent light unit.
See also Figure S2.
Steated from short-term in vitro studies can be used to deduce
the probability of cellular transitions between any two
phenotypic (e.g., differentiation) states. The model can
also be used to predict how genetic perturbations affect
cell-state interconversion rates; this allows us to infer, on
a dynamic level, how changes in gene function disrupt
cellular equilibrium.
We characterized the three main mammary epithelial
cell states isolated from MCF10A cells (Keller et al., 2010):
luminal (L) (CD24+/EPCAM+/CD49f+), basal (B) (CD24/
EPCAM/CD49f+), and stem (S) (CD24/EPCAM+/CD49f+)
(Figure 2B). As expected, expression analysis of 105 selected
genes that define different cell-differentiation states
confirmed that this sorting technique successfully isolates
populations of cells in each of the indicated cell-differentia-
tion states (Figure 2C). In addition, the shSlug cells
exhibited a higher percentage of cells in the luminal state
(shControl = 4% versus shSlug = 15%) and a lower percent-
age of cells in the basal state (shControl = 23% versus
shSlug = 7%), with no appreciable change in the stem state
(shControl = 73% versus shSlug = 78%) compared to the
control population (Figure 2D).
Based on these findings, L, B, and S sorted subpopula-
tions were allowed to expand in culture for 4 days, at which
time the proportion of cells in the luminal, basal, and stem
states were reanalyzed by flow cytometry (Figure 2E). For
each sorted subpopulation, there was an evident shift in
cell-state proportions, suggesting that cells were intercon-
verting between states (Figure 2F). In fact, SLUG inhibition
reduced the plasticity of cell transitions into the basal state
(L/B reduced 16-fold, S/B no longer present). In
contrast, SLUG inhibition increased the plasticity of cell
transitions from the stem state into the luminal state
(S/L increases 1.7-fold) and from the basal state into theons
CD49f) cell-surface markers in shControl (n = 3) and shSlug (n = 3)
ssion are shown. Data represent the mean ± SD, and p values were
CAM+/CD49f+), stem (CD24/EPCAM+/CD49f+), and basal (CD24/
10A population.
asal and stem subpopulations of MCF10A cells using the nCounter
ap displays selected genes that showed the greatest differential
e median centered.
nal, basal, and stem states in MCF10A shSlug and shControl parental
SD of six independent experiments, and p values were calculated by
ate transition probabilities in MCF10A shSlug and shControl cells.
Slug MCF10A cells. The table below summarizes the frequency of
’s fold change following SLUG inhibition is also displayed; only
wn. NA, not applicable.
em, and basal) of MCF10A shControl and shSlug cells. RFLU, relative
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SLUG Regulates Mammary Cell-State Transitionsstem state (B/S increases 2-fold; Figure 2F). Because the
S/B transitions were eliminated in shSlug cells, the
increased proportion of luminal cells was effectively due
to increased S/L transitions. Given that proliferation rates
did not vary between the luminal, basal, and stem states of
either parental line (Figure 2G), we could be confident that
the observed transitions were not a consequence of
differential growth rates inherent to each differentiation
state, but rather were due to changes in cellular plasticity.
Collectively, these findings, along with those above, reveal
that SLUG inhibition affects cellular differentiation in
addition to cellular plasticity, predominantly by altering
transitions arising from stem and basal cells; together, these
changes result in an unexpected accumulation of luminal
epithelial cells.
Loss of SLUG Promotes Aberrant Differentiation and
Mammary Progenitor Cell-State Transitions In Vivo
To determine if the above in vitro predictions of SLUG
deficiency are observed in vivo, we examined the mam-
mary glands of 16-week-old Snai2LacZ/LacZ mice; at this
age, steady-state homeostasis of luminal and basal progen-
itor cells is well established. In these mice, the zinc-finger
region of the Slug gene has been replaced by a b-galactosi-
dase gene, resulting in the production of a SLUG-b-galacto-
sidase fusion protein. The SLUG portion of this protein is
nonfunctional, as it lacks the zinc-finger region; thus,
mice homozygous for the Snai2LacZ/LacZ allele are func-
tional SLUG knockout mice (Jiang et al., 1998; Parent
et al., 2004).
Consistent with the increased proportions of luminal
cells observed in vitro, Snai2LacZ/LacZ mammary glandsFigure 3. SLUG Loss Promotes Aberrant Differentiation and Comp
(A and B) Flow cytometry analysis of luminal (CD24hi/CD49f/lo and
and EPCAMlo/CD49fhi), and luminobasal (EPCAMhi/CD49fhi) MEC p
mammary glands. Representative dot plots from a Snai2+/+ and Snai
circled in red. Arrow points to the luminobasal population. Bar charts
CD49f luminal and basal/ME (i) and luminobasal (ii). (B) CD24 versus C
two-tailed t test. CD24 versus CD49f: Snai2+/+, n = 11; Snai2LacZ/LacZ,
(C) Relative enrichment of mouse mature luminal, luminal progenitor,
the Snai2LacZ/LacZ luminobasal population (EPCAMhi/CD49fhi).
(D) Representative whole-mount and hematoxylin and eosin staining
glands (mice were 16 weeks). Arrowheads indicate hyperplastic term
(E) High-magnification H&E images of nulliparous Snai2+/+ and Snai2
tification indicates the percent of HTDUs observed in mammary whole
(IHC) staining for Ki67 (ii) and ER-a (iii) in nulliparous Snai2+/+ and Sn
indicates the percent of ER-a- or Ki67-positive cells per gland. Snai2+/+
old mice. Scale bars represent 100 mm. Error bars are ±SD, and p value
(F) Confocal immunofluorescent images of Snai2+/+ and Snai2LacZ/LacZ m
myoepithelial marker SMA (green). Nuclei were stained with DAPI (cya
EPCAM. The arrow highlights the aberrant filling of the ductal lumen
(G) Representative H&E images of mammary glands from Snai2+/+ a
phenotypes from Snai2LacZ/LacZ mammary glands are shown. Mice wer
Steexhibited a significant increase in the percentage of
CD24hi/CD49f/lo and EPCAMhi/CD49f/lo luminal cells
compared to WT controls (Figures 3Ai and 3B). This
increase in luminal cells by flow cytometry manifested
histologically as the formation of abnormal hyperplastic
terminal ductal units, with intraductal micropapillary
and solid growth patterns (Figures 3D and 3Ei). Notably,
luminal cells, which were both Ki67 and estrogen
receptor-a (ER-a) positive, accumulated within the lumens
of Snai2LacZ/LacZ glands, consistent with a luminal pro-
genitor state (Figures 3Eii and 3Eiii).
Also consistent with the in vitro findings, flow cytometry
analysis of mammary epithelial cells from Snai2LacZ/LacZ
mice revealed a significant reduction in the number of
EPCAMlo/CD49fhi basal/myoepithelial (ME) cells com-
pared to age-matched WT mice (with a similar, although
not statistically significant, downward trend in the
CD24med/CD49fhi basal/ME population; Figures 3Ai and
3B). Moreover, the EPCAMlo/CD49fhi basal cell population
of Snai2LacZ/LacZ mammary glands exhibited a significant
shift toward an EPCAMhi/CD49fhi state; termed the lumi-
nobasal state, this population reflected an altered basal
state that acquired distinct features of luminal differentia-
tion (Figure 3Aii). Consistent with this, genome-wide
expression analysis on sorted luminobasal cells from
Snai2LacZ/LacZ mammary glands revealed a significant
enrichment of luminal-related epithelial genes, including
several luminal cytokeratins and claudin tight junction
proteins (GEO accession number GSE55620), compared
to WT basal cells (EPCAMlo/CD49fhi). Additionally, when
probed for signatures of lineage-specific mouse mam-
mary epithelial subpopulations (Lim et al., 2009), theromises Normal Tissue Function In Vivo
EpCAMhi/CD49f/lo), basal/myoepithelial (ME) (CD24med/CD49fhi
opulations from 16-week nulliparous Snai2+/+ and Snai2LacZ/LacZ
2LacZ/LacZ mouse are shown. Luminal and basal/ME populations are
represent the percent of cells in each population. (A) EPCAM versus
D49f. Error bars are ±SEM, and p values were calculated by Student’s
n = 8. EPCAM versus CD49f: Snai2+/+, n = 5; Snai2LacZ/LacZ, n = 8.
basal/stem, and stromal signatures (defined by Lim et al., 2009) in
(H&E) images of nulliparous Snai2+/+ and Snai2LacZ/LacZ mammary
inal ductal units (HTDUs). Scale bars represent 100 mm.
LacZ/LacZ mammary glands (a HTDU structure is depicted) (i). Quan-
mounts. Snai2+/+, n = 5; Snai2LacZ/LacZ, n = 5. Immunohistochemical
ai2LacZ/LacZ mammary glands. Staining is quantified to the right and
, n = 4; Snai2LacZ/LacZ, n = 4. All analyses were performed on 16-week-
s were calculated by Student’s two-tailed t test.
ammary glands stained for the luminal marker EPCAM (red) and the
n). Arrowheads represent basal cells that are aberrantly expressing
with luminal cells. Scale bars represent 10 mm.
nd Snai2LacZ/LacZ mice on day 1 of lactation. Type I and type II
e mated at 16 weeks. Scale bars represent 100 mm.
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Figure 4. SLUG Loss Impairs Tissue Regeneration and Confers Resistance to Tumorigenesis
(A) Whole-mount analysis of mammary epithelial outgrowths 12 weeks after transplantation. A total of 50,000 MECs isolated from Snai2+/+
or Snai2LacZ/LacZ mammary glands (nulliparous, 16 weeks) were transplanted into the cleared fat pads of 3-week-old nonobese diabetic/
severe combined immunodeficiency (NOD/SCID) mice. Scale bars represent 200 mm. The extent to which each outgrowth filled the fat pad is
indicated by the ‘‘pie chart’’ symbols.
(legend continued on next page)
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SLUG Regulates Mammary Cell-State Transitionsluminobasal cells showed significant enrichment in
the luminal progenitor and mature luminal signatures
(Figure 3C).
Confocal dual-immunofluorescencemicroscopy analysis
for the luminal marker EPCAM and the basal/ME marker
SMA was also performed to validate the cellular differenti-
ation states of luminal and basal cells in Snai2LacZ/LacZ
mammary glands in situ. The analysis revealed two striking
details: (1) the population of aberrant cells filling the ductal
lumen of Snai2LacZ/LacZ mammary glands was predomi-
nantly of the luminal lineage (EPCAM+), but some
aberrantly expressed SMA, and (2) the outer basal/ME layer
of Snai2LacZ/LacZ mammary glands contained an uncharac-
teristic number of basal/ME cells coexpressing both basal
and luminal lineage markers, further supporting the
notion that SLUG deficiency causes basal cells to acquire
luminal features (Figure 3F).
Loss of SLUG Impairs Tissue Function and
Regeneration andConfers Resistance to Tumorigenesis
To determine whether the defects in luminal and basal pro-
genitor cells might alter tissue function, 16-week-old
female Snai2LacZ/LacZ mutant mice were examined for their
ability to undergo pregnancy-induced differentiation and
lactation. Although Snai2LacZ/LacZ mutant mice were fertile
and could give rise to viable pupswith similar efficiencies as
WT females, all of the pups nursed by the majority of
Snai2LacZ/LacZ mutant mice (five out of seven) died, with
pups appearing to have empty stomachs. Surprisingly, ex-
amination of mammary tissues from Snai2LacZ/LacZ mutant
mice that were unable to nurse their pups revealed two
prominent phenotypes: either (1) a block in alveologenesis
and failure to undergo lactational differentiation, sugges-
tive of luminal progenitor exhaustion (type I), or (2)
apparent normal alveolar differentiation and milk produc-
tion but evidence of premature involution (type II;
Figure 3G). Because Snai2LacZ/LacZ females presented no
obvious abnormal maternal nurturing behavior, this latter
phenotype suggested that when milk was produced in the
Snai2LacZ/LacZ mutant mice, it was not available to neo-(B) Kaplan-Meier tumor-free survival curves of FVB-Tg MMTV-Myc+ (n
Snai2+/+ mice (n = 7; purple). p values were calculated using the log
(C) MMTV-Myc tumor histopathology. Representative H&E staining of t
Scale bars represent 100 mm.
(D) Kaplan-Meier tumor-free survival curves of FVB/SV129-Tg MMTV-
Snai2LacZ/LacZ (n = 6; orange). p values were calculated using the log-
(E) Tumor burden curve for FVB-TgMMTV-Myc+ (parental, n = 14), FVB/S
FVB/SV129-Tg x Snai2LacZ/LacZ (n = 6) mice. Black bars represent the
Student’s two-tailed t test.
(F) Histologic features from tumors arising in FVB-Tg MMTV-Myc+ (n = 1
MMTV-Myc+ 3 Snai2LacZ/+ (n = 5) mice were examined. The tumors w
patterns.
Stenates. Given that basal/ME cells exhibited increased
luminal differentiation, we reasoned this failure of milk
ejectionmight be due to impaired function and contractile
activity of basal/ME cells. Consistent with this notion,
morphological and histological analyses revealed that
mammary glands from Snai2LacZ/LacZ dams contained large,
dilated ducts engorged with milk compared to WT glands
in which the ducts were empty due to efficient milk ejec-
tion. Collapsed alveoli and gland fragmentation, an indica-
tion of complete secretory tissue regression, were also
found in Snai2 mutant mammary epithelium (Figure 3F),
similar to those resulting from milk stasis when milk ejec-
tion is impaired in other contexts (Quarrie et al., 1996).
Taken together, our in vivo analysis of Snai2LacZ/LacZ mam-
mary epithelium confirms the in vitro predicted pheno-
type associated with altered cellular dynamics due to
SLUG inhibition. Furthermore, these findings demonstrate
that SLUG loss in mammary epithelial cells leads to defects
in basal/ME cell differentiation.
Given the defects in progenitor differentiation as well as
tissue function during pregnancy/lactation, we speculated
that stem cell activity necessary for tissue regeneration
following transplantation might also be compromised in
SLUG-deficient mammary epithelium. The mammary
transplantation assay activates committed progenitors to
adopt a more primitive state with extensive bipotent and
regenerative potential (Kordon and Smith, 1998; Shackle-
ton et al., 2006; Stingl et al., 2006; Van Keymeulen et al.,
2011). Consistent with the in vitro prediction that stem
cells can no longer transition into basal cells following
SLUG inhibition, transplantation of 50,000 Snai2LacZ/LacZ
MECs failed to generate any mammary outgrowths, while
nearly complete mammary repopulation was observed in
100% of the transplants from WT MECs (Figure 4A). This
suggested that SLUGmight be necessary formammary pro-
genitor cells to transition back into stem/basal states during
tissue regeneration in vivo.
Because tumor formation also requires activation of
primitive stem/basal cell programs (Youssef et al., 2012),
we crossed Snai2LacZ/LacZ mice onto the MMTV-Myc mouse= 12; red), FVB-Tg MMTV-Myc (n = 6; green) and FVB/SV129-Tg x
-rank test.
umors from FVB-Tg MMTV-Myc+, and FVB/SV129-Tg MMTV-Myc+ mice.
Myc+ mice: Snai2+/+ (n = 7; purple), Snai2LacZ/+ (n = 9; blue), and
rank test.
V129-Tg x Snai2+/+ (n = 7), FVB/SV129-Tg3 Snai2LacZ/+ (n = 9), and
median tumor burden for each cohort. p values were calculated by
4), FVB/SV129-Tg MMTV-Myc+3 Snai2+/+ (n = 6), and FVB/SV129-Tg
ere scored for the presence of the various dominant histological
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SLUG Regulates Mammary Cell-State Transitionsmammary tumormodel background to determine whether
defects inmammary progenitor cell-state transitionsmight
also affect tumorigenesis. MMTV-Myc+ mice develop het-
erogeneous tumors with various histologies and pheno-
types associated with both luminal and basal features,
including dominant luminal type tumors (microacinar
and papillary), dominant basal type tumors (squamous
and epithelial-to-mesenchymal transition), and mixed
solid and adenocarcinomas with features of both basal
and luminal differentiation (Andrechek et al., 2009; Sinn
et al., 1987). Snai2+/+/MMTV-Myc+ and Snai2LacZ/+/MMTV-
Myc+ compound mice also developed mammary adenocar-
cinomas with similar histologies and frequencies as
the parental MMTV-Myc+ mice (Figures 4B–4F). Strikingly,
however, Snai2LacZ/LacZ/MMTV-Myc+ compound mice com-
pletely failed to develop tumors by 70 weeks and thus were
resistant to mammary tumorigenesis (Figure 4D). Taken
together, these findings indicate that SLUG is necessary
for mammary epithelial cell plasticity and that transition-
ing back into more primitive stem-like states is a prerequi-
site for both tissue regeneration and tumor initiation.
A SLUG/LSD1 Histone-Modifying Complex Regulates
Gene Expression Programs in Basal Cells
Our findings have shown that SLUG is a critical regulator of
breast epithelial cell plasticity, cell-state transitions, and
differentiation. As a transcriptional repressor that mediates
sequence-specific interactions with DNA (Hemavathy
et al., 2000; Nieto, 2002), we hypothesized that SLUG
might be interacting with other proteins to transcription-Figure 5. A SLUG/LSD1 Complex Regulates Gene Expression in Ba
(A) Coimmunoprecipitation of endogenous SLUG and LSD1 from MCF1
(B) Western blot analysis of SLUG and LSD1 expression in shControl
analysis of SLUG and LSD1 mRNA levels (normalized to GAPDH) in s
represent the mean ± SD of three independent experiments, and p va
(C) Top: Venn diagrams showing the overlap of microarray-identified g
shLSD1 MCF10A cells compared to control cells. Bottom: Gene Ont
downregulated (ii) in shSlug and shLSD1 MCF10A cells compared to con
categories with an enrichment score >1.5; the enrichment score and
shown.
(D) Flow cytometry analysis of luminal (EPCAM) and basal (CD49f) cell
cells. Representative dot plots for EPCAM versus CD49f expression
experiments, and p values were calculated by Student’s two-tailed t t
(E) ChIP analysis showing profiles for SLUG and LSD1 localization along
LSD1 target genes (EPCAM, E-CAD and MUC1). Also depicted is relative
sites. Data are plotted as percent of input. ChIP was performed in shCo
two separate ChIP experiments was pooled, and enrichment was tested
RT-PCR array.
(F) Quantitative real-time PCR analysis of luminal marker expression
differentially expressed in the shSlug and shLSD1 cells compared to
change ± SD of three independent experiments, and p values were ca
(G) Schematic diagram showing the mechanism by which SLUG and L
See also Figure S3.
Steally control these various differentiation programs. To
identify interacting proteins that could cooperate with
SLUG to regulate gene expression, we performed immuno-
precipitation-coupled mass spectrometry by overexpress-
ing a FLAG-tagged SLUG in 293T cells. Consistent with a
recent report also using this approach, we found that
lysine-specific demethylase 1 (LSD1) coimmunopurifies
with SLUG (Figure S3A) (Wu et al., 2012). We confirmed
this endogenous interaction in both MCF10A and HMEC
basal progenitor cells (Figure 5A).
LSD1 is a histone demethylase whose transcriptional
repression activity has been correlated with enzymatic
removal of mono- and dimethyl groups from histone H3
Lysine 4 (H3K4; Shi et al., 2004; Wang et al., 2009). LSD1
hasbeen shown to interactwith the SNAGdomainof SNAIL
to regulate its activity and stability (Lin et al., 2010; Christo-
fori, 2010). Based on this, we hypothesized that SLUGmay
be recruiting LSD1 to specific sites on luminal and stem cell
gene promoters where it modifies histone marks associated
with active transcription to suppress lineage commitment
and differentiation and promote plasticity. In support of
this hypothesis, genome-wide expression analysis of
HMECs and MCF10A cells in which LSD1 had been
inhibited (Figure 5B; Figures S3B and S3C) identified a com-
mon set of epithelial-related genes whose expression was
similarly regulated upon SLUG knockdown (Figure 5C; Fig-
ure S3D). Additionally, similar to shSlug cells, inhibition of
LSD1 led to an increased proportion of EPCAM+ luminal
cells and a decreased proportion of EPCAM/CD49f+ basal
cells (Figures 2A and 5D; Figures S3E and S3F).sal Cells
0A cells (i), HMEC patient 1 (ii), and HMEC patient 2 (iii).
, shSlug, and shLSD1 MCF10A cells (i). Quantitative real-time PCR
hSlug and shLSD1 MCF10A cells relative to control cells (ii). Data
lues were calculated by Student’s two-tailed t test.
enes commonly upregulated (i) or downregulated (ii) in shSlug and
ology biological process categories commonly upregulated (i) or
trol cells. The DAVID Functional Annotation Tool was used to define
the p value of genes differentially expressed in each category are
-surface marker expression in shControl, shSlug and shLSD1 MCF10A
are shown. Data represent the mean ± SD of three independent
est.
the transcriptional start site (TSS;3 kb to 4 kb) of common SLUG/
enrichment of H3K4me3 (compared to total H3 levels) along these
ntrol, shSlug, and shLSD1 MCF10A cells. For each cell line, DNA from
at the indicated promoter regions using a customized quantitative
(normalized to GAPDH) in MCF10A shSlug and shLSD1 cells. Genes
the scrambled control cells are plotted. Bars represent the fold
lculated by Student’s two-tailed t test. *p < 0.05, **p < 0.01.
SD1 regulate cell-state dynamics in mammary epithelial cells.
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regulates MEC differentiation, a core set of SLUG/LSD1
target genes, including EPCAM, E-CADHERIN (E-CAD),
and MUC1, were used to evaluate SLUG recruitment of
LSD1 to their promoters. In addition, these genes were
used to examine whether the SLUG/LSD1 complex was
modifying histone marks to affect chromatin and gene
transcription. Chromatin immunoprecipitation (ChIP)
confirmed SLUG and LSD1 occupancy at the proximal
promoters of the indicated luminal epithelial genes (Fig-
ure 5E). Upon SLUG knockdown, SLUG and LSD1 occu-
pancy at these promoter regions was lost. This loss of
SLUG and LSD1 occupancy was accompanied by a signif-
icant increase in the LSD1-associated activating H3K4me3
histone mark (Saleque et al., 2007) at these promoters
(Figure 5E) and increased gene expression (Figure 5F).
Interestingly, upon LSD1 knockdown, SLUG and LSD1 oc-
cupancy at these promoter regions was also lost and gene
expression was increased; this suggested that LSD1 is
necessary for SLUG recruitment to these promoters. In
addition, LSD1 knockdown also led to increased
H3K4me3 histone marks at these promoters, although it
was not as robust as compared to SLUG knockdown.
This suggests that SLUG is necessary to recruit LSD1 in a
sequence-specific manner but that LSD1 is also necessary
for effective occupancy and histone demethylase activity
of the SLUG/LSD1 complex. Together, these findings
show that SLUG interaction with LSD1 is important to
modify chromatin and repress luminal gene expression
(Figure 5G).DISCUSSION
In this study, we uncover the complex connection between
cellular differentiation and cellular plasticity regulated by
SLUG, thus revealing how it impacts stem cell activity
during tissue homeostasis, function, regeneration, and
even the genesis of cancer. Our findings support a model
in which the transcription factor, SLUG, plays a dual role
in regulating MEC lineage identity; on the one hand, it
represses luminal epithelial differentiation, but on the
other it promotes stem cell-state transitions necessary for
transplantation and tumorigenesis. As a transcriptional
repressor of luminal differentiation, we showed that
SLUG interacts with LSD1 and recruits it to specific luminal
gene promoters where it demethylates H3K4 (Figure 5E). In
the absence of SLUG, LSD1 is no longer recruited to these
genes to modify chromatin; this results in the expression
of otherwise-repressed genes. Consistent with this, our
in vivo and in vitro observations showed that loss of
SLUG resulted in aberrant EPCAM expression in basal/ME
cells. As a regulator of progenitor cell dynamics, we found644 Stem Cell Reports j Vol. 2 j 633–647 j May 6, 2014 j ª2014 The Authorsthat SLUG also actively influences stem cell transitions.
In the absence of SLUG, cellular transitions from and into
the basal and stem cell states were compromised. This
was supported in vivo, where SLUG-deficient MECs were
unable to regenerate a mammary gland following trans-
plantation and were unable to form oncogene induced
mammary tumors; both processes require the transition
of basal progenitor cells into primitive stem-like states
not normally present during development (van Ameron-
gen et al., 2012; Van Keymeulen et al., 2011). Future studies
will be needed to determine whether LSD1 is also necessary
for repressing SLUG target genes that regulate stem cell
activity.
The observations that transplantation of Snai2LacZ/LacZ
mouse tissue fragments, rather than dissociated cells,
results in mature, highly branched mammary ductal trees
that infiltrate the entire fat pad (Nassour et al., 2012) and
that Snai2LacZ/LacZ mice exhibit normal embryonic and
pubertal mammary stem cell activity suggest that SLUG is
dispensable for normal mammary stem cell activity. How-
ever, our findings and those of others clearly show that
SLUG is necessary for mammary stem cell activity during
transplantation of dissociated cells (Figure 4A) (Guo et al.,
2012). These conflicting observations can be reconciled
by the differences in stem cell activity required during tis-
sue regeneration following transplantation of dissociated
cells from those used during ductal elongation of already-
established structures. Mammary tissues are regenerated
by unipotent lineage-restricted progenitor cells that can
expand to give rise to mature luminal or basal/ME cells
(Keller et al., 2011; van Amerongen et al., 2012; Van
Keymeulen et al., 2011). Therefore, dissociated cells must
adopt a bipotent fate upon transplantation, unlocking a
regenerative potential that is not normally used during
development (van Amerongen et al., 2012; Van Keymeulen
et al., 2011). Thus, our findings suggest that the cell-state
transitions necessary for this process require SLUG.
The dedifferentiation of lineage-committed cells into
more primitive stem-like states during transplantation is
similar to the cell-state transitions that occur during tumor
initiation (Keller et al., 2010). For example, preceding the
onset of basal cell carcinoma, adult tumor-initiating cells
are reprogrammed into a fate resembling embryonic hair
follicle progenitors (Youssef et al., 2012). Similarly, in a
model of intestinal cancer, epithelial non-stem cells have
been shown to dedifferentiate into tumor-initiating cells
(Schwitalla et al., 2013). These changes in cell-state transi-
tions are genetically and epigenetically controlled (Chaffer
et al., 2013; Pacheco-Pinedo et al., 2011), and here we show
that in the mammary gland, they require the transcription
factor SLUG.
Although epithelial cell-state conversions have been
shown to occur in vivo (Doupe´ et al., 2012; Wang et al.,
Stem Cell Reports
SLUG Regulates Mammary Cell-State Transitions2013), quantitative modeling of this dynamic process has
been challenging. We speculated that a Markov model pre-
viously used to study cell-state transitions of cancer cells
in vitro (Gupta et al., 2011) could also be used to uncover
important cell-state conversions in normal MEC popula-
tions; we also wondered whether the model’s predictions
could be tested in vivo. Accordingly, we applied the model
to normal, disease-free mammary epithelial cells in vitro
and found that it could accurately predict epithelial plas-
ticity in vivo. Remarkably, the model predicted that upon
loss of SLUG, there would be an accumulation of luminal
cells due to the increased probability that stem cells would
transition into luminal cells. Indeed, this phenotype was
observed in vivo in Snai2LacZ/LacZ mice. Thus, this approach
opens new possibilities for assessing the consequence of
genetic perturbations on cell-state transitions in normal
cells that can be used to predict and understand complex
phenotypes in vivo.EXPERIMENTAL PROCEDURES
Cell Lines and Tissue Culture
HMECs and MCF10A cells were cultured in mammary epithelial
growth medium (MEGM Bullet Kit; Lonza Corporation)
comprising mammary epithelial cell basal medium supplemented
with bovine pituitary extract (52 mg/ml), hydrocortisone
(0.5 mg/ml), human epidermal growth factor (10 ng/ml), and
insulin (5 mg/ml). MCF10A cells were further supplemented with
cholera toxin (100 ng/ml). For proliferation assays, cells were
plated in 96-well plates at 1,000 cells per well. On days 1, 2, and
3, cells were lysed with CellTiter-Glo Luminescent Cell Viability
Assay reagent (Promega) and luminescence was read using the
Sirius/FB15 Luminometer (Berthold).
Mouse Strains
The generation of Snai2LacZ/LacZ mice was described previously
(Jiang et al., 1998) and generously provided by Donna F. Kusewitt.
TheMMTV-Mycmouse (FVB-TgMMTV-Myc) used in this study has
been described elsewhere (Sinn et al., 1987).
Animal Surgery
All animal procedures were conducted in accordance with a
protocol approved by the Tufts University IACUC committee. A
colony of Snai2LacZ/LacZ, FVB-Tg MMTV-Myc+, and FVB/SV129-Tg
MMTV-Myc+3 Snai2LacZ/LacZmiceweremaintained in-house under
aseptic sterile conditions. Mice were administered autoclaved food
and water ad libitum. Surgeries were performed under sterile
conditions, and animals received antibiotics in the drinking water
up to 2 weeks after all surgical procedures.
ACCESSION NUMBERS
The GEO accession number for the human microarray data
reported in this paper is GSE54735. The GEO accession number
for the mouse microarray data is GSE55620.SteSUPPLEMENTAL INFORMATION
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